These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30336422)

  • 1. Oleoylethanolamide alleviates macrophage formation via AMPK/PPARα/STAT3 pathway.
    Zhao Y; Yan L; Peng L; Huang X; Zhang G; Chen B; Ren J; Zhou Y; Yang L; Peng L; Jin X; Wang Y
    Pharmacol Rep; 2018 Dec; 70(6):1185-1194. PubMed ID: 30336422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oleoylethanolamide stabilizes atherosclerotic plaque through regulating macrophage polarization via AMPK-PPARα pathway.
    Chen Z; Zhuo R; Zhao Y; Yang L; Zhou Y; Cheng X; Peng L; Jin X; Wang Y
    Biochem Biophys Res Commun; 2020 Apr; 524(2):308-316. PubMed ID: 31987499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-oleoylethanolamide suppresses intimal hyperplasia after balloon injury in rats through AMPK/PPARα pathway.
    Zhao Y; Liu Y; Jing Z; Peng L; Jin P; Lin Y; Zhou Y; Yang L; Ren J; Xie Q; Jin X
    Biochem Biophys Res Commun; 2018 Feb; 496(2):415-421. PubMed ID: 29305859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulatory effect of oleoylethanolamide in dendritic cells via TRPV1/AMPK activation.
    Yao E; Zhang G; Huang J; Yang X; Peng L; Huang X; Luo X; Ren J; Huang R; Yang L; Zhou Y; Zhuo R; Zhao Y; Jin X
    J Cell Physiol; 2019 Aug; 234(10):18392-18407. PubMed ID: 30895621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oleoylethanolamide Increases Glycogen Synthesis and Inhibits Hepatic Gluconeogenesis via the LKB1/AMPK Pathway in Type 2 Diabetic Model.
    Ren T; Ma A; Zhuo R; Zhang H; Peng L; Jin X; Yao E; Yang L
    J Pharmacol Exp Ther; 2020 Apr; 373(1):81-91. PubMed ID: 32024803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin inhibits monocyte-to-macrophage differentiation via AMPK-mediated inhibition of STAT3 activation: potential role in atherosclerosis.
    Vasamsetti SB; Karnewar S; Kanugula AK; Thatipalli AR; Kumar JM; Kotamraju S
    Diabetes; 2015 Jun; 64(6):2028-41. PubMed ID: 25552600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oleoylethanolamide exerts anti-inflammatory effects on LPS-induced THP-1 cells by enhancing PPARα signaling and inhibiting the NF-κB and ERK1/2/AP-1/STAT3 pathways.
    Yang L; Guo H; Li Y; Meng X; Yan L; Dan Zhang ; Wu S; Zhou H; Peng L; Xie Q; Jin X
    Sci Rep; 2016 Oct; 6():34611. PubMed ID: 27721381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orally administered oleoylethanolamide protects mice from focal cerebral ischemic injury by activating peroxisome proliferator-activated receptor α.
    Zhou Y; Yang L; Ma A; Zhang X; Li W; Yang W; Chen C; Jin X
    Neuropharmacology; 2012 Aug; 63(2):242-9. PubMed ID: 22480617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oleoylethanolamide, an endogenous PPAR-α ligand, attenuates liver fibrosis targeting hepatic stellate cells.
    Chen L; Li L; Chen J; Li L; Zheng Z; Ren J; Qiu Y
    Oncotarget; 2015 Dec; 6(40):42530-40. PubMed ID: 26729705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The identification of peroxisome proliferator-activated receptor alpha-independent effects of oleoylethanolamide on intestinal transit in mice.
    Cluny NL; Keenan CM; Lutz B; Piomelli D; Sharkey KA
    Neurogastroenterol Motil; 2009 Apr; 21(4):420-9. PubMed ID: 19140957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The OEA effect on food intake is independent from the presence of PPARα in the intestine and the nodose ganglion, while the impact of OEA on energy expenditure requires the presence of PPARα in mice.
    Caillon A; Duszka K; Wahli W; Rohner-Jeanrenaud F; Altirriba J
    Metabolism; 2018 Oct; 87():13-17. PubMed ID: 29936173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oleoylethanolamide inhibits glial activation via moudulating PPARα and promotes motor function recovery after brain ischemia.
    Luo D; Zhang Y; Yuan X; Pan Y; Yang L; Zhao Y; Zhuo R; Chen C; Peng L; Li W; Jin X; Zhou Y
    Pharmacol Res; 2019 Mar; 141():530-540. PubMed ID: 30660821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oleoylethanolamide attenuates apoptosis by inhibiting the TLR4/NF-κB and ERK1/2 signaling pathways in mice with acute ischemic stroke.
    Zhou H; Yang WS; Li Y; Ren T; Peng L; Guo H; Liu JF; Zhou Y; Zhao Y; Yang LC; Jin X
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Jan; 390(1):77-84. PubMed ID: 27738712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histamine-deficient mice do not respond to the antidepressant-like effects of oleoylethanolamide.
    Costa A; Cristiano C; Cassano T; Gallelli CA; Gaetani S; Ghelardini C; Blandina P; Calignano A; Passani MB; Provensi G
    Neuropharmacology; 2018 Jun; 135():234-241. PubMed ID: 29596898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oleoylethanolamide modulates glucagon-like peptide-1 receptor agonist signaling and enhances exendin-4-mediated weight loss in obese mice.
    Brown JD; McAnally D; Ayala JE; Burmeister MA; Morfa C; Smith L; Ayala JE
    Am J Physiol Regul Integr Comp Physiol; 2018 Oct; 315(4):R595-R608. PubMed ID: 29949410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oleoylethanolamide, a natural ligand for PPAR-alpha, inhibits insulin receptor signalling in HTC rat hepatoma cells.
    Martínez de Ubago M; García-Oya I; Pérez-Pérez A; Canfrán-Duque A; Quintana-Portillo R; Rodríguez de Fonseca F; González-Yanes C; Sánchez-Margalet V
    Biochim Biophys Acta; 2009 Aug; 1791(8):740-5. PubMed ID: 19345745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oleoylethanolamide dose-dependently attenuates cocaine-induced behaviours through a PPARα receptor-independent mechanism.
    Bilbao A; Blanco E; Luque-Rojas MJ; Suárez J; Palomino A; Vida M; Araos P; Bermúdez-Silva FJ; Fernández-Espejo E; Spanagel R; Rodríguez de Fonseca F
    Addict Biol; 2013 Jan; 18(1):78-87. PubMed ID: 23163925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AMP-activated protein kinase α1 promotes atherogenesis by increasing monocyte-to-macrophage differentiation.
    Zhang M; Zhu H; Ding Y; Liu Z; Cai Z; Zou MH
    J Biol Chem; 2017 May; 292(19):7888-7903. PubMed ID: 28330873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the satiety factor oleoylethanolamide in alcoholism.
    Bilbao A; Serrano A; Cippitelli A; Pavón FJ; Giuffrida A; Suárez J; García-Marchena N; Baixeras E; Gómez de Heras R; Orio L; Alén F; Ciccocioppo R; Cravatt BF; Parsons LH; Piomelli D; Rodríguez de Fonseca F
    Addict Biol; 2016 Jul; 21(4):859-72. PubMed ID: 26037332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anti-inflammatory vasostatin-2 attenuates atherosclerosis in ApoE
    Xiong W; Wang X; Dai D; Zhang B; Lu L; Tao R
    Thromb Haemost; 2017 Jan; 117(2):401-414. PubMed ID: 27831589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.